195 filings
S-3
PHGE
BiomX Inc
Shelf registration
29 Apr 24
4:31pm
8-K
PHGE
BiomX Inc
15 Apr 24
Departure of Directors or Certain Officers
5:19pm
S-8
PHGE
BiomX Inc
4 Apr 24
Registration of securities for employees
7:46am
10-K
2023 FY
PHGE
BiomX Inc
Annual report
4 Apr 24
6:30am
8-K
PHGE
BiomX Inc
3 Apr 24
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:40am
NT 10-K
3hrp1w092yn
1 Apr 24
Notice of late annual filing
4:02pm
D
wc8 0794y
1 Apr 24
$61.55 mm in equity / options / securities to be acquired, sold $61.55 mm, 34 investors
8:27am
8-K/A
mrpaxxyi pcxndqb
21 Mar 24
Departure of Directors or Certain Officers
4:18pm
8-K
1ylk99fcled7p
18 Mar 24
Completion of Acquisition or Disposition of Assets
7:27am
8-K
vjplfnh2tc663oe jy8
6 Mar 24
Form of Parent Stockholder Support Agreement
7:45am
EFFECT
t9q7d s0g
3 Jan 24
Notice of effectiveness
12:15am
CORRESP
eiod1z pb
29 Dec 23
Correspondence with SEC
12:00am
SC TO-I/A
82bsashw049 4zy5x
12 Dec 23
Issuer tender offer statement (amended)
4:20pm
8-K
zekb i59n2ocrx3j
7 Dec 23
Entry into a Material Definitive Agreement
5:29pm
8-K
t3kml6f9gudxe zu4yy
7 Dec 23
Other Events
4:09pm
8-K
2alykxw0f9tpjbauo
29 Nov 23
Revolutionizing the treatment of Cystic Fibrosis through our unique BOLT Phage therapy platform Investor Presentation / November 2023
6:37am
SC TO-I/A
n2bf0m
28 Nov 23
Issuer tender offer statement (amended)
4:01pm
CORRESP
9cp6xrwhg1e
28 Nov 23
Correspondence with SEC
12:00am